0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medicinal Radiocompounds Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-5D10933
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Medicinal Radiocompounds Market Research Report 2022
BUY CHAPTERS

Global Medicinal Radiocompounds Market Research Report 2025

Code: QYRE-Auto-5D10933
Report
March 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medicinal Radiocompounds Market Size

The global market for Medicinal Radiocompounds was valued at US$ 7986 million in the year 2024 and is projected to reach a revised size of US$ 13760 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Medicinal Radiocompounds Market

Medicinal Radiocompounds Market

Medicinal Radiocompounds refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Medicinal Radiocompounds are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medicinal Radiocompounds, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicinal Radiocompounds.
The Medicinal Radiocompounds market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medicinal Radiocompounds market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicinal Radiocompounds manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Medicinal Radiocompounds Market Report

Report Metric Details
Report Name Medicinal Radiocompounds Market
Accounted market size in year US$ 7986 million
Forecasted market size in 2031 US$ 13760 million
CAGR 8.2%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Technetium 99
  • Fluorine 18
  • Other
by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bracco Imaging, Bayer, Cardinal Health, Curium Pharma, Novartis, Lantheus, Acrotech Biopharma, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, SIEMENS, Dongcheng
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Medicinal Radiocompounds manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Medicinal Radiocompounds by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Medicinal Radiocompounds in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Medicinal Radiocompounds Market growing?

Ans: The Medicinal Radiocompounds Market witnessing a CAGR of 8.2% during the forecast period 2025-2031.

What is the Medicinal Radiocompounds Market size in 2031?

Ans: The Medicinal Radiocompounds Market size in 2031 will be US$ 13760 million.

Who are the main players in the Medicinal Radiocompounds Market report?

Ans: The main players in the Medicinal Radiocompounds Market are Bracco Imaging, Bayer, Cardinal Health, Curium Pharma, Novartis, Lantheus, Acrotech Biopharma, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, SIEMENS, Dongcheng

What are the Application segmentation covered in the Medicinal Radiocompounds Market report?

Ans: The Applications covered in the Medicinal Radiocompounds Market report are Oncology, Cardiology, Others

What are the Type segmentation covered in the Medicinal Radiocompounds Market report?

Ans: The Types covered in the Medicinal Radiocompounds Market report are Technetium 99, Fluorine 18, Other

Recommended Reports

Radiotherapy & Radiation

Diagnostics & Imaging

Pharmaceutical Products

1 Medicinal Radiocompounds Market Overview
1.1 Product Definition
1.2 Medicinal Radiocompounds by Type
1.2.1 Global Medicinal Radiocompounds Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Medicinal Radiocompounds by Application
1.3.1 Global Medicinal Radiocompounds Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Medicinal Radiocompounds Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Medicinal Radiocompounds Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Medicinal Radiocompounds Production Estimates and Forecasts (2020-2031)
1.4.4 Global Medicinal Radiocompounds Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Medicinal Radiocompounds Production Market Share by Manufacturers (2020-2025)
2.2 Global Medicinal Radiocompounds Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Medicinal Radiocompounds, Industry Ranking, 2023 VS 2024
2.4 Global Medicinal Radiocompounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Medicinal Radiocompounds Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Medicinal Radiocompounds, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Medicinal Radiocompounds, Product Offered and Application
2.8 Global Key Manufacturers of Medicinal Radiocompounds, Date of Enter into This Industry
2.9 Medicinal Radiocompounds Market Competitive Situation and Trends
2.9.1 Medicinal Radiocompounds Market Concentration Rate
2.9.2 Global 5 and 10 Largest Medicinal Radiocompounds Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Medicinal Radiocompounds Production by Region
3.1 Global Medicinal Radiocompounds Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Medicinal Radiocompounds Production Value by Region (2020-2031)
3.2.1 Global Medicinal Radiocompounds Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Medicinal Radiocompounds by Region (2026-2031)
3.3 Global Medicinal Radiocompounds Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Medicinal Radiocompounds Production Volume by Region (2020-2031)
3.4.1 Global Medicinal Radiocompounds Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Medicinal Radiocompounds by Region (2026-2031)
3.5 Global Medicinal Radiocompounds Market Price Analysis by Region (2020-2025)
3.6 Global Medicinal Radiocompounds Production and Value, Year-over-Year Growth
3.6.1 North America Medicinal Radiocompounds Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Medicinal Radiocompounds Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Medicinal Radiocompounds Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Medicinal Radiocompounds Production Value Estimates and Forecasts (2020-2031)
4 Medicinal Radiocompounds Consumption by Region
4.1 Global Medicinal Radiocompounds Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Medicinal Radiocompounds Consumption by Region (2020-2031)
4.2.1 Global Medicinal Radiocompounds Consumption by Region (2020-2025)
4.2.2 Global Medicinal Radiocompounds Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Medicinal Radiocompounds Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Medicinal Radiocompounds Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Medicinal Radiocompounds Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Medicinal Radiocompounds Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Medicinal Radiocompounds Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Medicinal Radiocompounds Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Medicinal Radiocompounds Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Medicinal Radiocompounds Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Medicinal Radiocompounds Production by Type (2020-2031)
5.1.1 Global Medicinal Radiocompounds Production by Type (2020-2025)
5.1.2 Global Medicinal Radiocompounds Production by Type (2026-2031)
5.1.3 Global Medicinal Radiocompounds Production Market Share by Type (2020-2031)
5.2 Global Medicinal Radiocompounds Production Value by Type (2020-2031)
5.2.1 Global Medicinal Radiocompounds Production Value by Type (2020-2025)
5.2.2 Global Medicinal Radiocompounds Production Value by Type (2026-2031)
5.2.3 Global Medicinal Radiocompounds Production Value Market Share by Type (2020-2031)
5.3 Global Medicinal Radiocompounds Price by Type (2020-2031)
6 Segment by Application
6.1 Global Medicinal Radiocompounds Production by Application (2020-2031)
6.1.1 Global Medicinal Radiocompounds Production by Application (2020-2025)
6.1.2 Global Medicinal Radiocompounds Production by Application (2026-2031)
6.1.3 Global Medicinal Radiocompounds Production Market Share by Application (2020-2031)
6.2 Global Medicinal Radiocompounds Production Value by Application (2020-2031)
6.2.1 Global Medicinal Radiocompounds Production Value by Application (2020-2025)
6.2.2 Global Medicinal Radiocompounds Production Value by Application (2026-2031)
6.2.3 Global Medicinal Radiocompounds Production Value Market Share by Application (2020-2031)
6.3 Global Medicinal Radiocompounds Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Bracco Imaging
7.1.1 Bracco Imaging Medicinal Radiocompounds Company Information
7.1.2 Bracco Imaging Medicinal Radiocompounds Product Portfolio
7.1.3 Bracco Imaging Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Bracco Imaging Main Business and Markets Served
7.1.5 Bracco Imaging Recent Developments/Updates
7.2 Bayer
7.2.1 Bayer Medicinal Radiocompounds Company Information
7.2.2 Bayer Medicinal Radiocompounds Product Portfolio
7.2.3 Bayer Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Bayer Main Business and Markets Served
7.2.5 Bayer Recent Developments/Updates
7.3 Cardinal Health
7.3.1 Cardinal Health Medicinal Radiocompounds Company Information
7.3.2 Cardinal Health Medicinal Radiocompounds Product Portfolio
7.3.3 Cardinal Health Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Cardinal Health Main Business and Markets Served
7.3.5 Cardinal Health Recent Developments/Updates
7.4 Curium Pharma
7.4.1 Curium Pharma Medicinal Radiocompounds Company Information
7.4.2 Curium Pharma Medicinal Radiocompounds Product Portfolio
7.4.3 Curium Pharma Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Curium Pharma Main Business and Markets Served
7.4.5 Curium Pharma Recent Developments/Updates
7.5 Novartis
7.5.1 Novartis Medicinal Radiocompounds Company Information
7.5.2 Novartis Medicinal Radiocompounds Product Portfolio
7.5.3 Novartis Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Novartis Main Business and Markets Served
7.5.5 Novartis Recent Developments/Updates
7.6 Lantheus
7.6.1 Lantheus Medicinal Radiocompounds Company Information
7.6.2 Lantheus Medicinal Radiocompounds Product Portfolio
7.6.3 Lantheus Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Lantheus Main Business and Markets Served
7.6.5 Lantheus Recent Developments/Updates
7.7 Acrotech Biopharma
7.7.1 Acrotech Biopharma Medicinal Radiocompounds Company Information
7.7.2 Acrotech Biopharma Medicinal Radiocompounds Product Portfolio
7.7.3 Acrotech Biopharma Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Acrotech Biopharma Main Business and Markets Served
7.7.5 Acrotech Biopharma Recent Developments/Updates
7.8 GE Healthcare
7.8.1 GE Healthcare Medicinal Radiocompounds Company Information
7.8.2 GE Healthcare Medicinal Radiocompounds Product Portfolio
7.8.3 GE Healthcare Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.8.4 GE Healthcare Main Business and Markets Served
7.8.5 GE Healthcare Recent Developments/Updates
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Medicinal Radiocompounds Company Information
7.9.2 China Isotope & Radiation Medicinal Radiocompounds Product Portfolio
7.9.3 China Isotope & Radiation Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.9.4 China Isotope & Radiation Main Business and Markets Served
7.9.5 China Isotope & Radiation Recent Developments/Updates
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Medicinal Radiocompounds Company Information
7.10.2 Jubilant Pharma Medicinal Radiocompounds Product Portfolio
7.10.3 Jubilant Pharma Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Jubilant Pharma Main Business and Markets Served
7.10.5 Jubilant Pharma Recent Developments/Updates
7.11 Eli Lilly
7.11.1 Eli Lilly Medicinal Radiocompounds Company Information
7.11.2 Eli Lilly Medicinal Radiocompounds Product Portfolio
7.11.3 Eli Lilly Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Eli Lilly Main Business and Markets Served
7.11.5 Eli Lilly Recent Developments/Updates
7.12 SIEMENS
7.12.1 SIEMENS Medicinal Radiocompounds Company Information
7.12.2 SIEMENS Medicinal Radiocompounds Product Portfolio
7.12.3 SIEMENS Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.12.4 SIEMENS Main Business and Markets Served
7.12.5 SIEMENS Recent Developments/Updates
7.13 Dongcheng
7.13.1 Dongcheng Medicinal Radiocompounds Company Information
7.13.2 Dongcheng Medicinal Radiocompounds Product Portfolio
7.13.3 Dongcheng Medicinal Radiocompounds Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Dongcheng Main Business and Markets Served
7.13.5 Dongcheng Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Medicinal Radiocompounds Industry Chain Analysis
8.2 Medicinal Radiocompounds Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Medicinal Radiocompounds Production Mode & Process Analysis
8.4 Medicinal Radiocompounds Sales and Marketing
8.4.1 Medicinal Radiocompounds Sales Channels
8.4.2 Medicinal Radiocompounds Distributors
8.5 Medicinal Radiocompounds Customer Analysis
9 Medicinal Radiocompounds Market Dynamics
9.1 Medicinal Radiocompounds Industry Trends
9.2 Medicinal Radiocompounds Market Drivers
9.3 Medicinal Radiocompounds Market Challenges
9.4 Medicinal Radiocompounds Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Medicinal Radiocompounds Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Medicinal Radiocompounds Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Medicinal Radiocompounds Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Medicinal Radiocompounds Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Medicinal Radiocompounds Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Medicinal Radiocompounds Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Medicinal Radiocompounds Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Medicinal Radiocompounds, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Medicinal Radiocompounds as of 2024)
 Table 10. Global Market Medicinal Radiocompounds Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Medicinal Radiocompounds, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Medicinal Radiocompounds, Product Offered and Application
 Table 13. Global Key Manufacturers of Medicinal Radiocompounds, Date of Enter into This Industry
 Table 14. Global Medicinal Radiocompounds Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medicinal Radiocompounds Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Medicinal Radiocompounds Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Medicinal Radiocompounds Production Value Market Share by Region (2020-2025)
 Table 19. Global Medicinal Radiocompounds Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Medicinal Radiocompounds Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Medicinal Radiocompounds Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Medicinal Radiocompounds Production (Tons) by Region (2020-2025)
 Table 23. Global Medicinal Radiocompounds Production Market Share by Region (2020-2025)
 Table 24. Global Medicinal Radiocompounds Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Medicinal Radiocompounds Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Medicinal Radiocompounds Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Medicinal Radiocompounds Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Medicinal Radiocompounds Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Medicinal Radiocompounds Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Medicinal Radiocompounds Consumption Market Share by Region (2020-2025)
 Table 31. Global Medicinal Radiocompounds Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Medicinal Radiocompounds Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Medicinal Radiocompounds Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Medicinal Radiocompounds Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Medicinal Radiocompounds Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Medicinal Radiocompounds Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Medicinal Radiocompounds Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Medicinal Radiocompounds Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Medicinal Radiocompounds Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Medicinal Radiocompounds Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Medicinal Radiocompounds Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Medicinal Radiocompounds Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Medicinal Radiocompounds Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Medicinal Radiocompounds Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Medicinal Radiocompounds Production (Tons) by Type (2020-2025)
 Table 46. Global Medicinal Radiocompounds Production (Tons) by Type (2026-2031)
 Table 47. Global Medicinal Radiocompounds Production Market Share by Type (2020-2025)
 Table 48. Global Medicinal Radiocompounds Production Market Share by Type (2026-2031)
 Table 49. Global Medicinal Radiocompounds Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Medicinal Radiocompounds Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Medicinal Radiocompounds Production Value Market Share by Type (2020-2025)
 Table 52. Global Medicinal Radiocompounds Production Value Market Share by Type (2026-2031)
 Table 53. Global Medicinal Radiocompounds Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Medicinal Radiocompounds Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Medicinal Radiocompounds Production (Tons) by Application (2020-2025)
 Table 56. Global Medicinal Radiocompounds Production (Tons) by Application (2026-2031)
 Table 57. Global Medicinal Radiocompounds Production Market Share by Application (2020-2025)
 Table 58. Global Medicinal Radiocompounds Production Market Share by Application (2026-2031)
 Table 59. Global Medicinal Radiocompounds Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Medicinal Radiocompounds Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Medicinal Radiocompounds Production Value Market Share by Application (2020-2025)
 Table 62. Global Medicinal Radiocompounds Production Value Market Share by Application (2026-2031)
 Table 63. Global Medicinal Radiocompounds Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Medicinal Radiocompounds Price (US$/Ton) by Application (2026-2031)
 Table 65. Bracco Imaging Medicinal Radiocompounds Company Information
 Table 66. Bracco Imaging Medicinal Radiocompounds Specification and Application
 Table 67. Bracco Imaging Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. Bracco Imaging Main Business and Markets Served
 Table 69. Bracco Imaging Recent Developments/Updates
 Table 70. Bayer Medicinal Radiocompounds Company Information
 Table 71. Bayer Medicinal Radiocompounds Specification and Application
 Table 72. Bayer Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Bayer Main Business and Markets Served
 Table 74. Bayer Recent Developments/Updates
 Table 75. Cardinal Health Medicinal Radiocompounds Company Information
 Table 76. Cardinal Health Medicinal Radiocompounds Specification and Application
 Table 77. Cardinal Health Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Cardinal Health Main Business and Markets Served
 Table 79. Cardinal Health Recent Developments/Updates
 Table 80. Curium Pharma Medicinal Radiocompounds Company Information
 Table 81. Curium Pharma Medicinal Radiocompounds Specification and Application
 Table 82. Curium Pharma Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Curium Pharma Main Business and Markets Served
 Table 84. Curium Pharma Recent Developments/Updates
 Table 85. Novartis Medicinal Radiocompounds Company Information
 Table 86. Novartis Medicinal Radiocompounds Specification and Application
 Table 87. Novartis Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Novartis Main Business and Markets Served
 Table 89. Novartis Recent Developments/Updates
 Table 90. Lantheus Medicinal Radiocompounds Company Information
 Table 91. Lantheus Medicinal Radiocompounds Specification and Application
 Table 92. Lantheus Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Lantheus Main Business and Markets Served
 Table 94. Lantheus Recent Developments/Updates
 Table 95. Acrotech Biopharma Medicinal Radiocompounds Company Information
 Table 96. Acrotech Biopharma Medicinal Radiocompounds Specification and Application
 Table 97. Acrotech Biopharma Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Acrotech Biopharma Main Business and Markets Served
 Table 99. Acrotech Biopharma Recent Developments/Updates
 Table 100. GE Healthcare Medicinal Radiocompounds Company Information
 Table 101. GE Healthcare Medicinal Radiocompounds Specification and Application
 Table 102. GE Healthcare Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. GE Healthcare Main Business and Markets Served
 Table 104. GE Healthcare Recent Developments/Updates
 Table 105. China Isotope & Radiation Medicinal Radiocompounds Company Information
 Table 106. China Isotope & Radiation Medicinal Radiocompounds Specification and Application
 Table 107. China Isotope & Radiation Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. China Isotope & Radiation Main Business and Markets Served
 Table 109. China Isotope & Radiation Recent Developments/Updates
 Table 110. Jubilant Pharma Medicinal Radiocompounds Company Information
 Table 111. Jubilant Pharma Medicinal Radiocompounds Specification and Application
 Table 112. Jubilant Pharma Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Jubilant Pharma Main Business and Markets Served
 Table 114. Jubilant Pharma Recent Developments/Updates
 Table 115. Eli Lilly Medicinal Radiocompounds Company Information
 Table 116. Eli Lilly Medicinal Radiocompounds Specification and Application
 Table 117. Eli Lilly Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Eli Lilly Main Business and Markets Served
 Table 119. Eli Lilly Recent Developments/Updates
 Table 120. SIEMENS Medicinal Radiocompounds Company Information
 Table 121. SIEMENS Medicinal Radiocompounds Specification and Application
 Table 122. SIEMENS Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. SIEMENS Main Business and Markets Served
 Table 124. SIEMENS Recent Developments/Updates
 Table 125. Dongcheng Medicinal Radiocompounds Company Information
 Table 126. Dongcheng Medicinal Radiocompounds Specification and Application
 Table 127. Dongcheng Medicinal Radiocompounds Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Dongcheng Main Business and Markets Served
 Table 129. Dongcheng Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Medicinal Radiocompounds Distributors List
 Table 133. Medicinal Radiocompounds Customers List
 Table 134. Medicinal Radiocompounds Market Trends
 Table 135. Medicinal Radiocompounds Market Drivers
 Table 136. Medicinal Radiocompounds Market Challenges
 Table 137. Medicinal Radiocompounds Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medicinal Radiocompounds
 Figure 2. Global Medicinal Radiocompounds Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Medicinal Radiocompounds Market Share by Type: 2024 VS 2031
 Figure 4. Technetium 99 Product Picture
 Figure 5. Fluorine 18 Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Medicinal Radiocompounds Market Value by Application, (US$ Million) & (2020-2031)
 Figure 8. Global Medicinal Radiocompounds Market Share by Application: 2024 VS 2031
 Figure 9. Oncology
 Figure 10. Cardiology
 Figure 11. Others
 Figure 12. Global Medicinal Radiocompounds Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Medicinal Radiocompounds Production Value (US$ Million) & (2020-2031)
 Figure 14. Global Medicinal Radiocompounds Production Capacity (Tons) & (2020-2031)
 Figure 15. Global Medicinal Radiocompounds Production (Tons) & (2020-2031)
 Figure 16. Global Medicinal Radiocompounds Average Price (US$/Ton) & (2020-2031)
 Figure 17. Medicinal Radiocompounds Report Years Considered
 Figure 18. Medicinal Radiocompounds Production Share by Manufacturers in 2024
 Figure 19. Global Medicinal Radiocompounds Production Value Share by Manufacturers (2024)
 Figure 20. Medicinal Radiocompounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. The Global 5 and 10 Largest Players: Market Share by Medicinal Radiocompounds Revenue in 2024
 Figure 22. Global Medicinal Radiocompounds Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 23. Global Medicinal Radiocompounds Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. Global Medicinal Radiocompounds Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 25. Global Medicinal Radiocompounds Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 26. North America Medicinal Radiocompounds Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Europe Medicinal Radiocompounds Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. China Medicinal Radiocompounds Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Japan Medicinal Radiocompounds Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Global Medicinal Radiocompounds Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 31. Global Medicinal Radiocompounds Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 32. North America Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. North America Medicinal Radiocompounds Consumption Market Share by Country (2020-2031)
 Figure 34. U.S. Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Canada Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. Europe Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. Europe Medicinal Radiocompounds Consumption Market Share by Country (2020-2031)
 Figure 38. Germany Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. France Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. U.K. Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Italy Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Russia Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. Asia Pacific Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Asia Pacific Medicinal Radiocompounds Consumption Market Share by Region (2020-2031)
 Figure 45. China Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Japan Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. South Korea Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. China Taiwan Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Southeast Asia Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. India Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. Latin America, Middle East & Africa Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Latin America, Middle East & Africa Medicinal Radiocompounds Consumption Market Share by Country (2020-2031)
 Figure 53. Mexico Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Brazil Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Turkey Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. GCC Countries Medicinal Radiocompounds Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 57. Global Production Market Share of Medicinal Radiocompounds by Type (2020-2031)
 Figure 58. Global Production Value Market Share of Medicinal Radiocompounds by Type (2020-2031)
 Figure 59. Global Medicinal Radiocompounds Price (US$/Ton) by Type (2020-2031)
 Figure 60. Global Production Market Share of Medicinal Radiocompounds by Application (2020-2031)
 Figure 61. Global Production Value Market Share of Medicinal Radiocompounds by Application (2020-2031)
 Figure 62. Global Medicinal Radiocompounds Price (US$/Ton) by Application (2020-2031)
 Figure 63. Medicinal Radiocompounds Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String